Abstract:Introduction and Objective The gold standard for the diagnosis of clinicallysignificant portal hypertension isrepresented by HVPG and Upper Gastrointestinalendoscopy is able to indirectlyassess the degree of portalhypertension through the evaluation of esophageal and/or gastric varices. Over the last 20 years, the introduction of non invasive tests (NITs) such asFibroscan has made it possibleto select patients with significantportal hypertension and therefore identify patients eligiblefor endoscopy. The BAVENO VII consensus identifies patientswho could benefit from endoscopy as those patientswith LSM ≥ 20 kPa assessed by TE and platelet count ≤ 150 × 109L. Moreover identifiesvalues of spleen stiffness to rulein and rule out portalhypertension such as SSM >50 kPa and SSM <21 kPa,respectively. Point-shear waveelastography and 2D-shear waveelastography have beenproposed as possible tools to non-invasively assess portalhypertension, but validation of the best cut-off is needed. Aim of this study is the evaluation of the role of 2D-Shear wave in non invasive diagnosis of portalhypertension. Methods From April 2022 to October 2023 we evaluated one hundred patients with chronichepatitis and cirrhosis (50 chronic hepatitis and 50 cirrhosis) whose baseline characteristics are presented in TABLE 1. All patients underwentabdominal ultrasound, liver and spleen stiffness (LS and SS) and liver and spleen 2D-shear wave(L2D-S and S2D-S); FIB-4 and the APRI score were alsocalculated. All cirrhotic patientsunderwent endoscopy to evaluate portal hypertension. Results The prevalence of varices in cirrhotic patients was50%. We found a statisticallysignificant correlation betwen LS and SS (p<0,001) and L2D-S and S2D-S (p<0,001) and the presence of varices, this was true also for APRI and FIB-4 (p<0,001), independently fromage, sex and BMI. We evaluated also the diagnostic performance for each individual test (Table 2), with an optimal cut-off 13.1 kPa and 12.5 kPa for LS and L2D-S (sensitivity 0.83 and 0.79, specificity 0.72 and 0.77, PPV 0.50 and 0.54, NPV 0.93 and 0.92 and AUROC 0.84 and 0.83 respectively), 45 kPa and 25 kPa for SS and S2D-S (sensitivity 0.77 and 0.91, specificity 0.89 and 0.66, PPV 0.69 and 0.47, NPV 0.92 and 0.96 and AUROC 0.88 and 0.80 respectively), 2.82 for FIB-4 (sensitivity 0.84, specificity 0.74, PPV 0.52, NPV 0.93 AUROC 0.80), 0.64 for APRI (sensitivity 0.72, specificity 0.70, PPV 0.44, NPV 0.88 AUROC 0.74). Each single test showed a low PPV for the prediction of oesophagealvarices (OV), however, when we combined the tests together wefound that the combination of LS and S2D-S showed a higher PPV for predicting OV (PPV 0.73; NPV 0.99). Conclusion We foundthat the combination of twotests (Liver stiffness and Spleen stiffness 2D-Shear wave) increases the probability of findingoesophageal varices and therefore can be useful for the non-invasive identification of patients with clinicallysignificant portalhypertension.

Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients

MR Elastography, T1 and T2 Relaxometry of Liver: Role in Noninvasive Assessment of Liver Function and Portal Hypertension

Combined model with acoustic radiation force impulse to rule out high-risk varices in HBV-related cirrhosis with viral suppression

Performance of Spleen Stiffness Measurement by 100-Hz Vibration-Controlled Transient Elastography, Liver Stiffness, APRI Score and their Combination for Predicting Oesophageal Varices in Liver Cirrhosis

Spleen Stiffness as Predictor of Esophageal Varices in Cirrhosis of Different Etiologies

Spleen stiffness: a new tool to predict high‐risk varices in cirrhotic patients

Spleen Thickness Plus Platelets Can Effectively and Safely Screen for High-Risk Varices in Cirrhosis Patients

Spleen and liver stiffness for noninvasive assessment of portal hypertension in cirrhotic patients with large esophageal varices

Platelet count/spleen volume ratio has a good predictive value for esophageal varices in patients with hepatitis B liver cirrhosis

Evaluation of Liver Fibrosis and Portal Hypertension in Chronic Hepatitis B Patients by Acoustic Radiation Force Impulse Elastography

Ultrasonic spleen thickness-based indexes surpass Baveno VI criteria in high-risk gastroesophageal varices detection

Evaluation of spleen stiffness by 2D shear wave elastography for ruling out high risk varices in patients with chronic advanced liver disease. A systematic review and meta-analysis

Role of P-shear wave hepatic elastography in prediction of high-risk varices in patients affected by compensated advanced chronic liver disease

Combining Spleen Diameter and the Baveno VI Criteria Assessed by 2-Dimensional Shear Wave Elastography to Rule Out High-Risk Varices

The relationship between platelet count to spleen sizes ratio,serum-ascites album gradient and esophageal varices in liver cirrhosis

The role of 2D-Shearwave elastography in non invasive portal hypertension diagnosis

Is ARFI elastography reliable for predicting fibrosis severity in chronic HCV hepatitis?

Shear Wave Dispersion Slope Measured with Shear Wave Dispersion Imaging Is Associated with Variceal Hemorrhage in Cirrhotic Patients

Improved Applicability and Diagnostic Accuracy of the Novel Spleen-Dedicated Transient Elastography Device for High-Risk Esophageal Varices

Predictive value of platelets-to-spleen diameter ratio for esophagogastric varices in hepatitis B virus-induced cirrhosis

Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients